Search for Clinical Trial Results
Diffuse Cutaneous Systemic Sclerosis - 25 Studies Found
Status | Study |
Active, not recruiting |
Study Name: A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis Condition: Diffuse Cutaneous Systemic Sclerosis Date: 2014-06-03 Interventions:
|
Completed |
Study Name: Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis Condition: Early Diffuse Cutaneous Systemic Sclerosis Date: 2014-12-22 Interventions:
|
Recruiting |
Study Name: Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis Condition:
Date: 2015-06-30 Interventions: |
Active, not recruiting |
Study Name: Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis Condition: Diffuse Cutaneous Systemic Sclerosis Date: 2015-06-04 Interventions:
|
Completed |
Study Name: Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis Condition: Systemic Sclerosis Date: 2012-08-15 Interventions: Drug: Belimumab Belimumab (Benlysta®) decreases B-Cell survival and has been FDA approved for the t |
Completed |
Study Name: Mycophenolate Mofetil in Systemic Sclerosis Condition: Diffuse Cutaneous Systemic Sclerosis Date: 2007-02-07 Interventions: Drug: Mycophenolate Mofetil Mycophenolate 3000 mg each day |
Completed |
Study Name: AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis Condition: Systemic Sclerosis Date: 2008-10-07 Interventions:
|
Not yet recruiting |
Study Name: Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2017-01-31 Interventions:
|
Withdrawn |
Study Name: A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) Condition: Scleroderma Date: 2015-10-26 Interventions:
|
Recruiting |
Study Name: Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension Condition:
|